Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Prezcobix approved in the U.S. for the treatment of adults with HIV-1

Feb. 2, 2015

EMA CHMP recommends approval of lamivudine/raltegravir for HIV-1 infection

Jan. 27, 2015

Laboratoire Biodim tests novel agents for HIV

Jan. 21, 2015

New data on the effect of PennVax-B in HIV-1-infected adults

Jan. 21, 2015

AB Science patents new SCFR inhibitors

Jan. 14, 2015

Argos Therapeutics reports results from phase IIb trial of AGS-004 in HIV-1 infection

Jan. 12, 2015

Merck & Co. reports new HIV integrase inhibitors

Jan. 7, 2015

Janssen and Gilead amend and expand HIV single-tablet regimen development agreements

Dec. 31, 2014

Merck & Co. reports CYP3A4 inhibitors to improve PK of anti-HIV drugs

Dec. 24, 2014

Chimerix and ContraVir establish strategic collaboration for CMX-157

Dec. 23, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...